Disease State Safety Efficacy Previous Next FACE IPF HEAD ON and modify disease progression by slowing lung function decline Adverse event management 24/05/2022 | Author: Boehringer IngelheimAdverse event management Document ID: PC-JO-100330 Safety Managing Nintedanib in CTD-ILD Adverse event management RELATED CONTENT Read more 3:50 PPF in CTD-ILD: How do we keep patients on treatment with nintedanib? PC-AE-102133 ( May 2026 ) Watch now Opens in new tab Home Ofev Safety Adverse event management
Read more 3:50 PPF in CTD-ILD: How do we keep patients on treatment with nintedanib? PC-AE-102133 ( May 2026 ) Watch now Opens in new tab